Collectively, these effects facilitate glucose uptake in peripheral tissues, reduce energy intake, and support weight loss [3, 4]
Given the intricate crosstalk between the gut microbiota and pharmacological interventions, personalised approaches that consider individual microbiome profiles and dietary habits could help optimise metabolic benefits and reduce the risk of AEs
Starting GLP-1 use with shared decision-making Like many medicines and treatments for chronic illnesses, the use of a GLP-1 is a decision that patients should make with the guidance of their providers
Not everyone gets nausea, but its one of the most reported early side effects
PubMed Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA (2006)
Your GP can assess whether symptoms relate to B12 intake, adjust dosing, or investigate alternative causes